Bio Green Med Solution, Inc. — Director's Dealing 2010

May 6, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2010-05-04

Reporting Person: Sosnowski Robert Edward (VP, Sales & Marketing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-04	Common Stock, $0.001 par value per share	M	10000	$.44	Acquired	10000	Direct
2010-05-04	Common Stock, $0.001 par value per share	S	10000	$2.5	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-05-04	Option	$0.44	M	10000	Disposed	2018-11-18	Common Stock (10000)	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Sosnowski.

F2: These securities were issued as part of the Issuer's annual equity compensation to executive officers on November 18, 2008.

F3: 23,333 of these options vested on November 18, 2009, the first anniversary of the grant date, and the balance of the options vest ratably on a monthly basis over the following 24 months.